Login
← Go Back
Marksans Pharma
MARKSANS · Pharma > Pharmaceuticals & Drugs · Chairman: Mark Saldanha · MD: Mark Saldanha · Listing date: Jan. 22, 2002 · Employees: 1138 · Mumbai · http://www.marksanspharma.com
Stock Price vs Company Growth
1d
1.6%
1w
1.9%
1m
0.6%
3m
22.2%
6m
111.6%
1y
102.4%
5y
37.8%
10y
20.1%
all
19.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 332 1.6%
239
351
Company Overview
Sales
3,172 Cr
Growth: 15.1%
Profit after Tax
517 Cr
Growth: 23.7%
Mid Cap
15,027 Cr
P/E: 29.1x
Industry P/E: 35.1x
Fundamentals
Sales (Cr) ₹ 3,172
Growth 15.1%
EBITDA 22.5%
P/S 4.7x
Dividend 0.4%
P/E 29.1x
Book Value ₹ 70.2
PEG Ratio 2.0x
ROE 17.9%
P/B 4.8x
Shareholding Pattern
Institutions
Promoters
Mark Saldanha
48.25 %
Others
Mukul Mahavir Prasad Agrawal
1.47 %
Increase    Decrease    No change
Company Profile Detailed
The company is a globally-trusted, customer-centric pharmaceutical company with a strong presence in regulated markets. The company specialises in developing and manufacturing & distributing both over-the-counter (OTC) and prescription (Rx) drugs, aligning its offerings with the evolving needs of patients and healthcare providers across the world.
Belongs to (14 Indices) view more
Investors (52)
mondrian...
kaushik5
merrill....
Followers (8)
akash2
karan3
sachin3